Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

(MRK)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
154.15(c) 153.75(c) 151.45(c) 153.6(c) 152(c) Last
245 545 384 050 399 671 255 184 573 188 Volume
-0.64% -0.26% -1.50% +1.42% -1.04% Change
More quotes
Financials
Sales 2021 18 882 M 22 392 M 22 392 M
Net income 2021 2 551 M 3 025 M 3 025 M
Net Debt 2021 8 694 M 10 311 M 10 311 M
P/E ratio 2021 25,6x
Yield 2021 1,00%
Sales 2022 19 832 M 23 519 M 23 519 M
Net income 2022 2 734 M 3 242 M 3 242 M
Net Debt 2022 6 474 M 7 678 M 7 678 M
P/E ratio 2022 24,0x
Yield 2022 1,06%
Capitalization 66 086 M 78 348 M 78 373 M
EV / Sales 2021 3,96x
EV / Sales 2022 3,66x
Nbr of Employees 57 850
Free-Float 29,7%
More Financials
Company
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The... 
Sector
Pharmaceuticals
Calendar
07/12Presentation
More about the company
Ratings of MERCK Kommanditgesellschaft auf Aktien
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
06/15MERCK KGAA  : Berenberg gives a Neutral rating
MD
06/10Volkswagen, Nine Others Set Up Quantum Technology & Application Consortium
MT
06/10MERCK  : Obtains Halal Certifications For All Cosmetics Products
MT
06/10PRESS RELEASE : ObsEva Presents PROLONG Phase 2a Proof-of-Concept Data on Ebopip..
DJ
06/09MERCK KGAA  : UBS reaffirms its Neutral rating
MD
06/02Germany to build up reserve vaccine capacity to fight future pandemics
RE
06/02PRESS RELEASE : CureVac Appoints Klaus Edvardsen as Chief Development Officer
DJ
06/01Immutep, Merck KGaA Expand Collaboration in Solid Tumors
MT
06/01Merck KgaA Partners With Immutep For Trial In Solid Tumor Patients
MT
06/01Immutep in Collaboration, Supply Agreement With Merck KGaA
DJ
06/01PRESS RELEASE : Immunic, Inc. Announces Appointment of Inderpal Singh as General..
DJ
05/31Immutep Partners With Merck KGaA in Clinical Trial for Tumor Treatment; Share..
MT
05/31MERCK  : Names Chief Science & Technology Officer
MT
05/28MERCK KGAA  : Berenberg reiterates its Neutral rating
MD
05/27Merck KGaA Ties Up With Two Universities On Bioreactor Designs
MT
More news
News in other languages on MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
06/18Aktien Frankfurt Eröffnung: Rekordhoch beim MDax am grossen Verfallstag
06/17PTA-NEWS  : 4SC AG: 4SC & NKI kooperieren bei der klinischen Evaluierung von Dom..
06/15MÄRKTE EUROPA/DAX vor Fed-Sitzung weiter freundlich
06/11MÄRKTE EUROPA/Gut behauptet - fallende Renditen stützen
06/10Deutsche Konzerne wollen Quantencomputing voranbringen
More news
Analyst Recommendations on MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
More recommendations
Chart MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Duration : Period :
MERCK Kommanditgesellschaft auf Aktien Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 151,31 €
Last Close Price 152,00 €
Spread / Highest target 21,7%
Spread / Average Target -0,45%
Spread / Lowest Target -26,3%
EPS Revisions
Managers and Directors
NameTitle
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors